Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.
Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Garcia F, et al. Among authors: martinez madrid oj. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19520. doi: 10.7448/IAS.17.4.19520. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394029 Free PMC article.
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
Poveda E, Hernández-Quero J, Pérez-Elías MJ, Ribas MA, Martínez-Madrid OJ, Flores J, Navarro J, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestaran A, García F, Paredes R; PROTEST study group. Poveda E, et al. Among authors: martinez madrid oj. HIV Med. 2017 Aug;18(7):482-489. doi: 10.1111/hiv.12479. Epub 2016 Dec 30. HIV Med. 2017. PMID: 28035758 Free article. Clinical Trial.
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study.
Portilla J, Arazo P, Crusells J, Pérez-Martínez L, Martínez-Madrid O, Boix V, Moreno J, Navarro V, Rubio T, Reus S, Galera C, Bernal E, Jover F, Amador C, Baño D, Merino E, Saiz-de-la-Hoya P. Portilla J, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19803. doi: 10.7448/IAS.17.4.19803. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397547 Free PMC article.
Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
Portilla J, Boix V, Garcia-Henarejos JA, Llopis C, Martínez-Madrid O, Gimeno A, Sánchez-Paya J, Merino E. Portilla J, et al. Int J STD AIDS. 2005 Dec;16(12):807-10. doi: 10.1258/095646205774988082. Int J STD AIDS. 2005. PMID: 16336763 Clinical Trial.
Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects.
Genebat M, Vera F, Hernández-Quero J, Domingo P, Guardiola JM, Martínez-Madrid O, Martínez L, de la Llana FG, Sánchez-Villegas J, Alvarez H, Mariño A, Lluch JF, Martínez-Pérez MA, Marín J, Ruiz-Mateos E, Leal M. Genebat M, et al. Antiviral Res. 2014 Apr;104:59-61. doi: 10.1016/j.antiviral.2014.01.019. Epub 2014 Jan 31. Antiviral Res. 2014. PMID: 24491797
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
Pernas M, Tarancón-Diez L, Rodríguez-Gallego E, Gómez J, Prado JG, Casado C, Dominguez-Molina B, Olivares I, Coiras M, León A, Rodriguez C, Benito JM, Rallón N, Plana M, Martinez-Madrid O, Dapena M, Iribarren JA, Del Romero J, García F, Alcamí J, Muñoz-Fernández M, Vidal F, Leal M, Lopez-Galindez C, Ruiz-Mateos E. Pernas M, et al. J Virol. 2018 Feb 12;92(5):e01805-17. doi: 10.1128/JVI.01805-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29212942 Free PMC article.
Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control.
Rodríguez-Gallego E, Tarancón-Diez L, García F, Del Romero J, Benito JM, Alba V, Herrero P, Rull A, Dominguez-Molina B, Martinez-Madrid O, Martin-Pena L, Pulido F, León A, Rodríguez C, Rallón N, Peraire J, Viladés C, Leal M, Vidal F, Ruiz-Mateos E; HIV-1 Elite Controllers Study Group (ECRIS), Spanish AIDS Research Network. Rodríguez-Gallego E, et al. J Infect Dis. 2019 Feb 23;219(6):867-876. doi: 10.1093/infdis/jiy599. J Infect Dis. 2019. PMID: 30312441 Free article.
[Pregnancy and HIV infection: the need for routine serological evaluation].
Alcalde Encinas MM, Moreno Guillén S, Piñera Salmerón P, García Henarejos JA, García García J, Martínez Madrid OJ. Alcalde Encinas MM, et al. Among authors: martinez madrid oj. Rev Clin Esp. 1999 Sep;199(9):569-72. Rev Clin Esp. 1999. PMID: 10568147 Spanish.
18 results